Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001704400-17-000001
Filing Date
2017-06-20
Accepted
2017-06-20 10:01:20
Documents
1
Effectiveness Date
2017-06-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10779
  Complete submission text file 0001704400-17-000001.txt   11799
Mailing Address 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA 02130
Business Address 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA 02130 617-441-7200
Anelixis Therapeutics, Inc. (Filer) CIK: 0001704400 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-289051 | Film No.: 17919997